Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 7 studies | 30% ± 6% | |
endothelial cell | 6 studies | 22% ± 6% | |
type II pneumocyte | 6 studies | 37% ± 7% | |
microglial cell | 5 studies | 25% ± 7% | |
astrocyte | 5 studies | 33% ± 8% | |
macrophage | 5 studies | 23% ± 4% | |
type I pneumocyte | 5 studies | 26% ± 3% | |
oligodendrocyte precursor cell | 4 studies | 22% ± 6% | |
epithelial cell | 3 studies | 29% ± 10% | |
GABAergic neuron | 3 studies | 35% ± 3% | |
glutamatergic neuron | 3 studies | 38% ± 4% | |
alveolar macrophage | 3 studies | 20% ± 4% | |
monocyte | 3 studies | 21% ± 3% | |
fibroblast | 3 studies | 18% ± 1% | |
brush cell | 3 studies | 30% ± 9% | |
adipocyte | 3 studies | 16% ± 0% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1788.48 | 1445 / 1445 | 100% | 6.01 | 183 / 183 |
intestine | 100% | 1850.50 | 966 / 966 | 100% | 5.19 | 527 / 527 |
lung | 100% | 2626.04 | 578 / 578 | 100% | 5.94 | 1155 / 1155 |
stomach | 100% | 1162.43 | 359 / 359 | 100% | 4.92 | 286 / 286 |
thymus | 100% | 1661.31 | 653 / 653 | 100% | 6.87 | 603 / 605 |
skin | 100% | 1795.39 | 1809 / 1809 | 100% | 9.20 | 470 / 472 |
kidney | 100% | 1279.73 | 89 / 89 | 100% | 4.73 | 897 / 901 |
breast | 100% | 1716.32 | 459 / 459 | 100% | 4.66 | 1113 / 1118 |
prostate | 100% | 1533.10 | 245 / 245 | 99% | 3.40 | 499 / 502 |
uterus | 100% | 2021.48 | 170 / 170 | 99% | 5.00 | 456 / 459 |
bladder | 100% | 1598.14 | 21 / 21 | 99% | 4.80 | 500 / 504 |
brain | 98% | 840.94 | 2596 / 2642 | 100% | 5.66 | 705 / 705 |
ovary | 100% | 1893.58 | 180 / 180 | 98% | 3.03 | 422 / 430 |
pancreas | 99% | 705.25 | 324 / 328 | 98% | 4.57 | 175 / 178 |
adrenal gland | 100% | 1184.96 | 257 / 258 | 96% | 3.21 | 220 / 230 |
liver | 100% | 973.68 | 225 / 226 | 95% | 2.83 | 384 / 406 |
adipose | 100% | 1529.15 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2014.72 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 4.41 | 29 / 29 |
muscle | 100% | 1529.99 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1665.84 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 5.51 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.39 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 99% | 9.95 | 79 / 80 |
heart | 97% | 924.50 | 838 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 87% | 1032.32 | 805 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000023 | Biological process | maltose metabolic process |
GO_0006491 | Biological process | N-glycan processing |
GO_0004558 | Molecular function | alpha-1,4-glucosidase activity |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0032450 | Molecular function | maltose alpha-glucosidase activity |
Gene name | GANC |
Protein name | Glucosidase alpha, neutral C Neutral alpha-glucosidase C (EC 3.2.1.20) Glucosidase, alpha neutral C |
Synonyms | |
Description | FUNCTION: Has alpha-glucosidase activity. . |
Accessions | ENST00000440615.6 A0A0G2JLA2 H3BMW3 H3BRQ6 ENST00000318010.13 H3BMM3 ENST00000562170.5 ENST00000567784.5 ENST00000562859.5 H3BN99 E7EWB6 ENST00000570013.5 Q8TET4 ENST00000566442.5 Q2M2A3 ENST00000561871.1 |